This inventor holds 2 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1996-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takarazuka, JP (1996)
- Suita, JP (2001)
Company Filing History:
Years Active: 1996-2001
Title: Hiroki Itoh: Innovator in Pharmaceutical Preparations
Introduction
Hiroki Itoh is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stabilized preparations. With a total of 2 patents to his name, Itoh's work has the potential to enhance the stability and efficacy of pharmaceutical compositions.
Latest Patents
Hiroki Itoh's latest patents include a "Stabilized Pharmaceutical Preparation" and a "Stabilized Vitamin D Preparation." The stabilized pharmaceutical preparation features a coating agent that protects against light, particularly ultraviolet rays, while producing free radicals. This innovative approach ensures excellent storage stability. The stabilized vitamin D preparation, on the other hand, involves dispersing heat-labile vitamin D in a basic polymer and an excipient that is soluble in organic solvents. This composition minimizes isomerization, decomposition, and discoloration, showcasing remarkable stability.
Career Highlights
Itoh is associated with Takeda Chemical Industries, Inc., a leading company in the pharmaceutical sector. His work at Takeda has allowed him to focus on developing advanced pharmaceutical formulations that address critical stability issues.
Collaborations
Hiroki Itoh has collaborated with esteemed colleagues such as Jun-ichi Kikuta and Makoto Fukuta. These partnerships have contributed to the innovative research and development efforts within the pharmaceutical industry.
Conclusion
Hiroki Itoh's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug stability and efficacy. His patents reflect a deep understanding of the challenges in pharmaceutical formulations, making him a valuable asset in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
